Document is current

Article History

Received: 23 September 2025

Accepted: 24 November 2025

First Online: 4 May 2026

Change Date: 30 July 2026

Change Type: Update

Change Details: The original online version of this article was revised: The footnote “The German version of this article can be found under

Change Details: https://doi.org/https://link.springer.com/article/10.1007/s00101-025-01621-7

Change Details: ” was missing.

Declarations

Conflict of interest: F. Piekarski received lecture fees from CSL Behring and travel and continuing education reimbursement from Edwards Lifesciences and Abbott. He is Chair of the Point of Care Working Group of the Interdisciplinary Working Group for Clinical Hemotherapy (Interdisziplinäre Arbeitsgemeinschaft für Klinische Hämotherapie e. V). M. Coburn received lecture fees from Baxter, Dräger, and Abbott. He is Chair of the Research Committee of the European Society of Anaesthesiology and Intensive Care (ESAIC), Chair of the Sustainability Forum of the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), and Chair of the German Society of Anaesthesiology and Intensive Care (GSAIC) Trials Group of the DGAI. J. Menzenbach, T. Hilbert, J. Hersch, E. Schindler and J. Grabert declare that they have no competing interests.

: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.

: The supplement containing this article is not sponsored by industry.